PCRX - Pacira BioSciences, Inc.
22.86
0 0%
Share volume: 931,883
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$22.86
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 07-30-2024 | 11-06-2024 | 02-27-2025 | 05-08-2025 | 08-05-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 1.583 B | 1.647 B | 1.522 B | 1.554 B | 1.587 B | 1.537 B | 1.298 B | 1.265 B | |
| Current Assets | 543.113 M | 632.214 M | 689.969 M | 745.130 M | 759.962 M | 745.613 M | 562.751 M | 547.974 M | |
| Inventories | 96.782 M | 103.438 M | 111.865 M | 125.282 M | 133.754 M | 148.163 M | 157.680 M | 152.863 M | |
| Other Current Assets | 18.802 M | 19.771 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 18.802 M | 19.771 M | 207.845 M | 207.841 M | 210.016 M | 145.380 M | 98.745 M | 79.879 M | |
| Total Receivables | 101.639 M | 104.779 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 325.890 M | 404.226 M | 245.965 M | 276.774 M | 283.610 M | 300.484 M | 147.589 M | 158.545 M | |
| Total Non-current Assets | 1.040 B | 1.015 B | 36.726 M | 35.649 M | 28.031 M | 18.810 M | 20.271 M | 22.308 M | |
| Property Plant Equipment | 171.804 M | 168.850 M | 166.852 M | 167.169 M | 164.451 M | 155.178 M | 147.388 M | 140.690 M | |
| Other Assets | 36.542 M | 36.499 M | 664.870 M | 641.217 M | 662.256 M | 636.471 M | 587.438 M | 576.253 M | |
| Intangible Assets | 468.936 M | 454.614 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 163.243 M | 163.243 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.583 B | 1.647 B | 1.522 B | 1.554 B | 1.587 B | 1.537 B | 1.298 B | 1.265 B | |
| Total liabilities | 691.159 M | 767.542 M | 772.108 M | 775.168 M | 788.128 M | 779.495 M | 570.363 M | 571.806 M | |
| Total current liabilities | 93.444 M | 92.690 M | 306.401 M | 309.920 M | 314.732 M | 313.164 M | 107.078 M | 120.590 M | |
| Accounts Payable | 8.982 M | 18.730 M | 19.367 M | 19.133 M | 23.172 M | 30.124 M | 17.687 M | 15.150 M | |
| Other liabilities | 33.582 M | 35.406 M | 79.816 M | 81.703 M | 85.110 M | 83.653 M | 81.977 M | 74.814 M | |
| Current long term debt | 8.641 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 511.687 M | 589.300 M | 385.891 M | 383.545 M | 381.290 M | 378.095 M | 376.721 M | 372.189 M | |
| Other liabilities | 33.582 M | 35.406 M | 79.816 M | 81.703 M | 85.110 M | 83.653 M | 81.977 M | 74.814 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 892.162 M | 879.278 M | 749.583 M | 778.348 M | 798.541 M | 757.767 M | 727.214 M | 693.111 M | |
| Common stock | 46.499 M | 46.174 M | 996.423 M | 1.009 B | 1.024 B | 1.036 B | 1.050 B | 1.065 B | |
| Retained earnings | -97.817 M | -78.931 M | -222.397 M | -206.356 M | -201.544 M | -206.391 M | -200.959 M | -199.322 M |